. Author manuscript; available in PMC: 2023 Dec 13.

Published in final edited form as: Clin Cancer Res. 2023 Jun 13;29(12):2266–2279. doi: 10.1158/1078-0432.CCR-22-1488

Table 1.

Cox uni- and multivariate analysis of SIGLEC16 and polySia status in relation to OS (MHH and UMG cohorts combined)

	Univariate		Multivariate ^a
Variable	HR ^b (95% CI)	P	HR (95% CI)	P
SIGLEC16	0.51 (0.31 - 0.70)	P < 0.0001 ^c	0.53 (0.38 - 0.74)	P = 0.0002

polySia	0.56 (0.38 - 0.87)	P = 0.0064	0.69 (0.46 - 1.07)	P = 0.086

SIGLEC16 / polySia double-positive	0.50 (0.36 - 0.69)	P < 0.0001	0.55 (0.39 - 0.77)	P = 0.0007

Multivariate analysis adjusted for cohort, age at tumor resection, sex, gross total resection, and chemotherapy. For covariates, see Supplementary Table S3

Abbreviations: HR, hazard ratio; CI, confidence interval

P-values < 0.05 are shown in bold